3 Reasons to attend online:

1. Understand how to most efficiently develop global evidence that can best provide value to key local markets

2. Benchmark what are today’s and tomorrow’s ideal market access & cross-functional capabilities to maximise effectiveness in larger or smaller companies

3. Appreciate how to best leverage evidence to demonstrate value to key payers and HTAs

Speakers List

INDUSTRY EXPERTS

Vice President National Accounts/Pricing
Stryker 

Former Foundation Medicine Access Innovation and PHC Lead, Pharma International, F. Hoffmann-La Roche
Chair of the “Funding Medical Technologies” group, MedTech Europe

Market & Business Insights Manager EMEA
Smith & Nephew

Director, Market Access & Economic Policies
MedTech Europe

Chief Market Access & Strategy Officer 
Implantica 

Secretary General
EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs

Senior Manager Health Policy & Economics EMEA
Zoll

 

Global Access & Business Intelligence Manager

Echosens

International Sales Director Italy, Central Europe, Russia and Eurasia
Echosens

Academic Perspective

Professor of Public Health
University of Aix-Marseille 

Guest Professor, Health Economic Evidence 
University of Ghent

EXPERIENCED SOLUTION PROVIDERS

Principal and Founder
Hull Associates

CEO and Founder
ValueConnected

Event Structure

Event Overview

STRATEGIES FOR EVIDENCE DEVELOPMENT & VALUE DEMONSTRATION

Day 70 - 20th April, 2022

THE IMPACT OF EVIDENCE GENERATION ON REIMBURSEMENT AGREEMENTS

Day 69 - 21st April, 2022

EVENT PARTNERS

Related Videos

Presentation

How value-based approach is transforming the MedTech industry

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • Integrating market access, medical affairs and deep clinical understanding
  • Building a strategy with KOL engagement and collaboration with scientific societies - a case study explaining the process and decision-making algorithms
  • Clinical guidelines, the reimbursement system and medical standards and protocols as a key focus of the strategy
Speaker

Julya Zuenkova

Business Development Director
Xstrahl Group

Presentation

From value-based healthcare to network value

Related topics: MedTech, Market Access & HEOR
Availability: FREE

COVID-19 significantly impacted how providers reach out to patients. Besides, there has been a series of changes in the reimbursement and funding of medical technologies and procedures. These aspects created opportunities to address new market needs and leverage data and learning to deliver more value to a growing network of payers, providers, and patients. Welcome to the new era of Network Value.

Speaker

Ernesto M. Nogueira

CEO and Founder
ValueConnected

View Agenda or Register